Caxton Associates (UK)’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-4,816
Closed -$222K – 792
2025
Q3
$222K Sell
4,816
-4,793
-50% -$256K 0.01% 615
2025
Q2
$508K Buy
+9,609
New +$508K 0.01% 426

Other funds holding CNXC

Caxton Associates (UK)'s CNXC Position: Q4 2025 in Review

Caxton Associates (UK) sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 4,816 shares — an estimated $222K sold.

Caxton Associates (UK) first reported a position in CNXC in Q2 2025 and held it in 2 quarters. The position peaked at $508K in Q2 2025. 337 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Caxton Associates (UK) reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 4,816 Concentrix shares in Q4 2025, an estimated $222K.
  • Caxton Associates (UK) first reported a position in Concentrix in Q2 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Concentrix position peaked at $508K in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Caxton Associates (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.